We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 09, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS
HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS
TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
DEVICE FOR DISPLAYING FLOWER BOUQUETS OR POTTED PLANTS
TYMPANIC MEMBRANE REPAIR DEVICE
VIRAL INHIBITOR COMPOSITION FOR IN VIVO THERAPEUTIC USE
THIXOTROPIC BIOLOGICAL ADHESIVE FOR USE IN INTERNAL BODY CAVITIES